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For Campylobacter spp., no internationally accepted 
criteria for susceptibility testing including assessments 
of breakpoints for susceptible versus resistant isolates are 
available. Therefore, routine susceptibility testing of 
Campylobacter in the clinical microbiology laboratory is 
often not performed. For therapeutic agents, the 
breakpoints established for aerobic bacteria are often 
used. However, the extrapolation of such breakpoints 
to other bacteria like campylobacters, which require 
special growth conditions, may be questioned. 
Campylobacteriosis is considered to be a zoonotic 
disease, and emergence of antimicrobial resistance in 
enteric Campylobacter spp., due to the use of anti- 
microbial agents in husbandry, is a matter of concern 
[l-41. In Denmark, more than 80% of the cases of 
campylobacteriosis are estimated to be domestically 
acquired from food and to a lesser extent drinking 
water [5]. In order to survey the antimicrobial suscepti- 
bility patterns of thermophilic Campylobacter spp. 
isolated from food animals, food of animal origin and 
humans in different laboratories, the same standardized 
or intercalibrated methods should be applied. MIC 
determinations are normally considered to be the 
standard for susceptibility testing. However, a variety of 
Werent methods, including a s i o n  tests, are routinely 
used in clinical laboratories. Thus, comparative studies 
on the performance of diffusion testing procedures 
versus MIC determinations are needed. In the present 
study, we have compared the results obtained by the 
methods used in four clinical, veterinary and food 
microbiology reference laboratories in Denmark. 
In total, 24 human clinical isolates, 24 isolates from 
cattle, 24 isolates from broilers and 24 isolates from 
swine were included in the study (59 Campylobacter 
jejuni, 36 C. coli and one C. lari). The reference strains 
CCUG 26277 (C. jejuni] and CCUG 11283 (C. coli], 
were included. Isolates from humans originated f k m  
stools of clinical cases of diarrhea submitted to Statens 
Serum Institut. Isolates from food animals originated 
from fecal samples taken at the time of slaughter from 
healthy animals and submitted to the Danish Veterinary 
Laboratory as part of the surveillance scheme for 
antimicrobial resistance in Denmark. 
The isolates were randomly selected from a stock 
culture collection known to have a variety of suscepti- 
bility characteristics with respect to the antimicrobial 
agents included in the present study. The isolates 
had been identified to the species level on the basis 
of standardized conventional methods: morphology, 
motility, catalase, oxidase, indoxyl acetate hydrolysis, 
hippurate hydrolysis, and susceptibility to nalidixic acid 
and cephalothin [6]. 
Subcultures from a single colony for each isolate 
were performed and isolates were distributed to the 
participating laboratories frozen in filtered serum broth 
with 10% glycerol. 
Apart from method A, all isolates were tested twice 
on two different days to allow for day-to-day variation, 
and results therefore consist of an average of two values. 
For quality control, the following reference strains 
were included: Staphylococcus aureus (ATCC 25923), 
Escherichia coli (ATCC 25922), Pseudomonas aerugi- 
nosa (ATCC 27853) and Enterococcus faecalis (ATCC 
29212). 
The following antimicrobial agents were tested 
nalidixic acid, erythromycin, streptomycin and tetra- 
cycline. For the agar dilution methods, the antibiotics 
were bought &om Sigma Chemical Company, St Louis, 
MO, USA. Study C: AB Biodisk, Solna, Sweden. 
Studes D and E: Rosco, Taastrup, Denmark. 
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AGAR DILUTION WITH YEAST-ENRICHED DANISH BLOOD 
AGAR METHOD A 
The dilution ranges were as follows: erythromycin and 
tetracycline, 0.03 1-256 mg/L; nalidxic acid, 1-256 
mg/L; and streptomycin, 0.5-256 mg/L. MIC deter- 
minations were performed by the agar dilution method 
with a yeast-enriched 5% Danish blood agar plate (SSI 
Diagnostica, Hillercld, Denmark). All MIC plates were 
inoculated with 1 pL of approximately lo7 CFU/mL 
with a Denley multipoint inoculator (Denley Instru- 
ments, Billingshurst, UK), resulting in lo4 CFU/spot. 
The plates were incubated for 24 h at 37°C in a micro- 
aerobic atmosphere (5% 0 2 ,  5% COz, 90% Nz). A pilot 
study (data not presented) had shown that sufficiently 
good growth of thermophilic Campylobacter spp. could 
be achieved on the medium within 24 h of incubation. 
The MIC was defined as the lowest con-centration 
producing three or fewer colonies. 
AGAR DILUTION WITH MUELLER-HINTON H AGAR 
METHOD B 
The dilution ranges were as follows: erythromycin and 
tetracycline, 0.25-32 mg/L; nalidixic acid and strepto- 
mycin, 1-128 mg/L. MIC determinations were per- 
formed by the agar dilution method with Mueller- 
Hinton I1 agar (Becton Dickinson Microbiology 
Systems, Cockeyville, MD, USA.) supplemented with 
5% bovine blood. All MIC plates were inoculated with 
approximately lo4 CFU following the procedure of 
Tenover et a1 [7]. The plates were incubated for 48 h at 
37°C in a micro-aerobic atmosphere (6% 0 2 ,  7% COz, 
7% H2, 80% N2). The MIC was defined as the lowest 
concentration producing no visible growth. 
ETEST WITH YEAST-ENRICHED DANISH BLOOD AGAR: 
METHOD C 
This method was performed by the application of Etest 
strips on a swab-inoculated, yeast-enriched 5% Danish 
blood agar dish (SSI Diagnostica). Concentrations of all 
antimicrobial agents ranged &om 0.016 mg/L to 256 
mg/L. To diminish moisture in the dishes, they were 
allowed to dry with lids ajar for 15 min before use. The 
inoculum, obtained from a 24-h-old culture, was 
standardized according to the direct colony suspension 
method described by the NCCLS [8], but with a 
turbidity equal to a no. 6 McFarland standard to achieve 
satisfactory growth after 24 h of incubation. Two drops 
of this suspension were pipetted and evenly distributed 
over the entire surface of a 140-mm dried agar dish 
using a bent glass rod. After application of the strips 
with forceps, each dish was incubated at 37°C in a 
micro-aerobic atmosphere (5% 0 2 ,  5% COz, 90% N2). 
with no more than 10 dishes stacked together. MICs 
were determined after 24 h of incubation by reading 
the corresponding value listed on the Etest strip scale, 
where the eliptical zone of inhibition intersected the 
strip, Because of observed swarm into areas of inhibited 
growth, the veil of swarming growth was ignored. 
AGAR DIFFUSION WITH YEAST-ENRICHED DANISH BLOOD 
AGAR: METHOD D 
This method was performed by the application of 
antibiotic tablets on the same type of plate as in method 
C. To diminish moisture in the dishes, they were 
allowed to dry with lids ajar for 15 min before use. 
The antibiotic contents of the tablets were as follows: 
tetracycline 80 pg, erythromycin 78 pg, streptomycin 
100 pg and nalidixic acid 130 pg. The inocula were the 
same and prepared in the same way as for method C. 
After application of the tablets by a tablet dispenser, 
each dish was incubated at 37°C in a micro-aerobic 
atmosphere (5% 0 2 ,  5% CO2, 90% Nz). Measurement 
of zone diameters was made from the zone edge of 
complete inhibition. Because of observed swarm into 
areas of inhibited growth, the veil of swarming growth 
was ignored. 
AGAR DIFFUSION WITH BLOOD AGAR BASE 2 (OXOID): 
METHOD E 
This method is based upon embedding of a bacterial 
inoculum in agar followed by application of the same 
antibiotic tablets as in method D to the agar surface. An 
inoculum of 0.3 mL (10' CFU/mL) was prepared from 
three loops of fresh colony material in 2 mL of 0.9% 
NaC1, and mixed thoroughly with 60 g of autoclaved 
and liquid (48.0+1.0°C) blood agar base No. 2 
(Oxoid, Basingstoke, UK) in sterile 140-mm Petri 
dishes. After the agar had solidified, the dishes were 
dried for 30 min at room temperature in a laminar 
airflow bench. The four antibiotic tablets were applied 
on the surface of each dish and incubated at 420°C for 
48 h in a micro-aerobic atmosphere of approximately 
6% 02,7% COz, 7%Hz, 80% Nz. 
Interpretive criteria for breakpoints were deter- 
mined by comparison of the distribution of the 
population of MICs for methods A-C and zones of 
inhibition for methods D and E. For the clinically 
relevant agent, erythromycin, a regression line between 
methods A and D was produced. 
The distribution of the susceptibilities of all four 
antibiotics with all five methods was bimodal, with 
breakpoints at clinically achievable levels. The per- 
centage of sensitive isolates was virtually the same for 
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each agent, regardless of the method: nalidixic acid 
92-94%, erythromycin 82-83%, streptomycin 85% and 
tetracycline 98%. 
As an example for the distribution of MICs the 
data for method A is presented in Table 1. 
With the tentative breakpoints listed in Table 2, 
there was complete agreement between the three 
o*o 0 
Table 1 The distribution of the population of MICs for 
method A for the four antimicrobial agents 
0.25 - 
Nalidixic 
MIC acid Erythromycin Tetracycline Streptomycin 
0 0 0  



































































MIC methods with regard to separating isolates into 
susceptible and resistant populations when tested for all 
four antimicrobial agents. However, for nahdixic acid, 
two isolates were resistant according to MIC methods 
(MIC ranges 32-64 mg/L) but had zones of inhbition 
between 26 and 31 mm with the two tablet diffusion 
methods. For erythromycin, the regression line for 
zone versus MIC for methods A and D showed good 
correlation (Figure 1, r2=0.87). 
Within the group of susceptible isolates, the 
distribution of dfferences was assessed for each 
antimicrobial agent (Table 3). Because of differences in 
ranges between MIC methods, out-of-range values are 
not included in the calculations presented in Table 3. 
There is at present no internationally accepted 
standard procedure for susceptibility testing of Camp+ 
bacter, and a variety of methods are used. In the present 
study, we have compared five hfferent methods in 
order to assess the comparability of results obtained in 
different laboratories. There was agreement concerning 
the separation of nahdxic acid MICs into susceptible 
and resistant groups. For this agent, the Etest had a 
tendency to produce lower values compared to the 
two agar ddution methods (Table 3). However, these 
discrepancies in dilutions were mostly some distance 
from the breakpoint and did not cause problems with 
MIC, mg/L 
1024 1 
Figure 1 Erythromycin, regression line for zone versus MIC (methods A and D). Asterix indicates 12 values. Regression 
line: y = -12.76~ + 569,7; r2 = 0.87. 
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respect to the overall purpose of the present study: the 
separation of isolates into susceptible and resistant 
groups. 
The proper separation of isolates is of major 
importance, as nalidixic acid is used to identify 
Cutnpylobucter to the species level [6], even though at 
present there is no zone diameter criterion for defining 
susceptibility to this agent. Resistance of C. jejuni and 
C. coli to quinolones is emerging in many countries 
[9-121. This will cause problems with species identi- 
fication when this is performed solely by phenotypic 
tests, the most frequently used method for differen- 
tiating Cumpylobucter spp. in routine laboratories 
[13,14]. More noteworthy is the fact that nalidixic acid 
susceptibility is a marker for C. jejuni and C. coli 
ciprofloxacin susceptibility; the nalidixic acid-susceptible 
strains are susceptible to ciprofloxacin, while most of 
the resistant ones are resistant to ciprofloxacin [lo, 151. 
A high level of nalidixic acid is therefore indicative of 
resistance to ciprofloxacin, an important drug of choice 
for the treatment of severe invasive campylobacteriosis 
[16]. The level of nalidixic acid resistance in C. jejuni 
isolated from humans in Denmark has previously been 
assessed by methods A and D, and is approximately 
Table 2 Tentative breakpoints for the four antimicrobial 
agents 
Antimicrobial MIC methods Tablet methods 
agents ( m g 4  (mm) 
Nalidixic acid SS16; R 2 3 2  S226;  R 1 1 7  
Erythromycin S S 8 ;  R 2 6 4  S227;  R 1 2 0  
Streptomycin S116;  R S 3 2  SS31; R 1 2 5  
Tetracycline S14;  R 2 3 2  S225;  R 1 1 8  
S, susceptible; R ,  resistant. 
10-15% [17,18]. This moderate level can be attributed 
to the infrequent use of antibiotics for the treatment of 
diarrhea in Denmark and the fact that the veterinary 
use of quinolones for therapy of infections has so far 
been relatively limited. In the present study, all methods 
agreed in categorizing the naturally resistant C. luri 
isolate as resistant to nalidixic acid. 
The general tendency of the Etest to produce 
lower values than the agar dilution methods was more 
pronounced for erythromycin than for nalidixic acid. 
The tendency was mainly seen at very low MICs, and 
therefore did not interfere with the interpretation of 
results. Resistance to erythromycin is more frequent in 
C. coli than in C. jejuni [17,18]. In the present study, 
42% of C. coli and 3% of C. jejuni isolates were resistant 
to erythromycin. The agent is considered to be the 
drug of first choice when simple rehydration and 
electrolyte replacement is not sufficient for the treat- 
ment of Campylobacter enteritis [16,19]. The reliability 
of the reported susceptibility testing on this agent is 
therefore of major clinical importance. Our regression 
line in Figure 1 indicates that the tablet method may 
constitute a simple, inexpensive and accurate means of 
susceptibility testing of Cumpylobucter for erythromycin. 
For streptomycin and tetracycline, there was com- 
plete agreement between all five methods. For both 
agents, a large number of isolates had MICs out of 
range, so the calculations in Table 3 are based upon 
moderate numbers, 16 and 25 respectively. As shown 
in Table 3 ,  method B resulted in lower values than 
methods A and C when tested for streptomycin. 
Interpretation was clearcut for tetracycline because of 
full agreement between methods and MICs and zones 
of inhibitions clearly away from the breakpoint. 
Correlation analysis with this antibiotic is weakened by 
Table 3 Distribution of differencesb in MICs for susceptible isolates (%) 
Antimicrobial agent N" Methods < -2 -3 -1 0 +1 +2 > + 2  
~ ~~ ~ 
a N inmcates number of susceptible isolates for whch comparison was performed 
further. 
Zero indlcates percentage of isolates for which MICs are identical within one ddutlon; - 1 and + 1 etc inmcate? 1 log2 ddution dlfference 
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the low occurrence of resistance in the isolates in the 
study. The tetracyline-resistant C. jejuni reference strain 
was correctly categorized as resistant by all five methods, 
indicating that the low occurrence of resistance to 
tetracycline is correct and not methodological. Low 
levels of resistance to tetracycline in Denmark have 
previously been shown for both C. jejuni and C. coli 
[ 17,181. 
In conclusion, the Etest had a tendency to produce 
lower values compared to agar ddutions when tested 
against nahdixic acid and erythromycin. In contrast, 
method B resulted in lower values compared to the two 
other MIC methods when tested against streptomycin. 
However, both methods were able to separate isolates 
unequivocally into susceptible and resistant groups, and 
the findings are therefore of minor significance. 
Even though monitoring of the resistance for 
surveillance purposes is performed in different labora- 
tories and with different techniques, our study indicates 
that reliable results can be achieved for comparison. 
However, the interpretive criteria that we have suggested 
must be considered tentative because of the low level 
of resistance to some antibiotics among a moderate 
number of isolates at study. It would be appropriate to 
evaluate these tentative criteria in a larger multicenter 
study, including a variety of antibiotics that have 
clinical, diagnostic or epidemiologic relevance. 
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